{"nct_id": "NCT03899155", "age": "Adults", "cancer_center_accrual_goal_upper": 0, "data_table4": "Interventional", "drug_list": {"drug": [{"drug_name": "Drug: Regorafinib"}, {"drug_name": "Drug: Enzalutamide"}, {"drug_name": "Drug: Pembrolizumab"}, {"drug_name": "Drug: Capecitabine"}, {"drug_name": "Drug: Rucaparib"}, {"drug_name": "Drug: Oxaliplatin"}, {"drug_name": "Drug: Relatlimab"}, {"drug_name": "Drug: Sunitinib"}, {"drug_name": "Drug: Fluorouracil"}, {"drug_name": "Drug: Ipilimumab"}, {"drug_name": "Drug: Trametinib"}, {"drug_name": "Drug: Daratumumab"}, {"drug_name": "Drug: Nivolumab + Relatlimab"}, {"drug_name": "Drug: Nivolumab"}, {"drug_name": "Drug: Temozolomide"}, {"drug_name": "Drug: Leucovorin"}, {"drug_name": "Drug: Pemetrexed"}, {"drug_name": "Drug: Cabozantinib"}, {"drug_name": "Drug: Bevacizumab"}]}, "long_title": "Pan-Tumor Study for Long-term Treatment of Cancer Patients Who Have Participated in BMS Sponsored Trials Investigating Nivolumab and Other Cancer Therapies", "management_group_list": {"management_group": [{"is_primary": "Y", "management_group_name": "Group1"}]}, "oncology_group_list": {"oncology_group": [{"group_name": "Group1", "is_primary": "N"}]}, "phase": "PHASE2", "principal_investigator": "Bristol-Myers Squibb", "principal_investigator_institution": "Bristol-Myers Squibb", "program_area_list": {"program_area": [{"is_primary": "Y", "program_area_name": "Program1"}]}, "protocol_id": 0, "protocol_no": "", "protocol_target_accrual": 1500, "protocol_type": "INTERVENTIONAL", "prior_treatment_requirements": ["Inclusion Criteria:", "* Signed Written Informed Consent.", "* Eligible to receive continued study treatment per the Parent Study, including treatment beyond progression per investigator assessment in the Parent Study.", "* On treatment hold in the Parent Study following long-lasting response or are eligible for treatment rechallenge as defined in the Parent Study.", "* WOCBP and male participants who are sexually active must agree to follow instructions for method(s) of contraception as described below and included in the ICF.", "Exclude - Exclusion Criteria:", "Exclude - * Participant is not eligible for study treatment per the Parent Study eligibility criteria.", "Exclude - * Participants not receiving clinical benefit as assessed by the Investigator.", "Exclude - * Any clinical adverse event (AE), laboratory abnormality, or intercurrent illness which, in the opinion of the Investigator, indicates that participation in the study is not in the best interest of the participant.", "Exclude - * Other protocol-defined Inclusion/Exclusion Criteria apply"], "short_title": "Pan Tumor Rollover Study", "site_list": {"site": []}, "sponsor_list": {"sponsor": [{"is_principal_sponsor": "Y", "sponsor_name": "Bristol-Myers Squibb", "sponsor_protocol_no": "", "sponsor_roles": "sponsor"}]}, "staff_list": {"protocol_staff": []}, "status": "open to accrual", "summary": "Main Objective of this study is to examine long-term safety of nivolumab monotherapy including combinations and other cancer therapies in various tumor types.", "treatment_list": {"step": [{"arm": [{"arm_code": "A1: Nivolumab Monotherapy Dose 1", "arm_internal_id": 0, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Nivolumab", "level_internal_id": 0, "level_suspended": "N"}]}, {"arm_code": "A2: Nivolumab Monotherapy Dose 2", "arm_internal_id": 1, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Nivolumab", "level_internal_id": 0, "level_suspended": "N"}]}, {"arm_code": "B1: Nivolumab + Ipilimumab", "arm_internal_id": 2, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Nivolumab", "level_internal_id": 0, "level_suspended": "N"}, {"level_code": "1", "level_description": "Drug: Ipilimumab", "level_internal_id": 1, "level_suspended": "N"}]}, {"arm_code": "B2: Nivolumab + Ipilimumab + Cabozantinib", "arm_internal_id": 3, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Nivolumab", "level_internal_id": 0, "level_suspended": "N"}, {"level_code": "1", "level_description": "Drug: Ipilimumab", "level_internal_id": 1, "level_suspended": "N"}, {"level_code": "2", "level_description": "Drug: Cabozantinib", "level_internal_id": 2, "level_suspended": "N"}]}, {"arm_code": "B3: Nivolumab + Ipilimumab + Trametinib", "arm_internal_id": 4, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Nivolumab", "level_internal_id": 0, "level_suspended": "N"}, {"level_code": "1", "level_description": "Drug: Ipilimumab", "level_internal_id": 1, "level_suspended": "N"}, {"level_code": "2", "level_description": "Drug: Trametinib", "level_internal_id": 2, "level_suspended": "N"}]}, {"arm_code": "C1: Relatlimab + Nivolumab Fixed Dose Combination Dose 1", "arm_internal_id": 5, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Nivolumab + Relatlimab", "level_internal_id": 0, "level_suspended": "N"}]}, {"arm_code": "C3: Relatlimab + Nivolumab Fixed Dose Combination Dose 2", "arm_internal_id": 6, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Nivolumab + Relatlimab", "level_internal_id": 0, "level_suspended": "N"}]}, {"arm_code": "C2: Relatlimab + Nivolumab Single Agent Vial (SAV) Dose 1", "arm_internal_id": 7, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Nivolumab", "level_internal_id": 0, "level_suspended": "N"}, {"level_code": "1", "level_description": "Drug: Relatlimab", "level_internal_id": 1, "level_suspended": "N"}]}, {"arm_code": "C4: Relatlimab + Nivolumab SAV Dose 2", "arm_internal_id": 8, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Nivolumab", "level_internal_id": 0, "level_suspended": "N"}, {"level_code": "1", "level_description": "Drug: Relatlimab", "level_internal_id": 1, "level_suspended": "N"}]}, {"arm_code": "C5: Relatlimab + Nivolumab + Ipilimumab", "arm_internal_id": 9, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Nivolumab", "level_internal_id": 0, "level_suspended": "N"}, {"level_code": "1", "level_description": "Drug: Ipilimumab", "level_internal_id": 1, "level_suspended": "N"}]}, {"arm_code": "C6: Relatlimab + Nivolumab + Capecitabine", "arm_internal_id": 10, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Nivolumab + Relatlimab", "level_internal_id": 0, "level_suspended": "N"}, {"level_code": "1", "level_description": "Drug: Capecitabine", "level_internal_id": 1, "level_suspended": "N"}]}, {"arm_code": "C7: Relatlimab + Nivolumab SAV Dose 3", "arm_internal_id": 11, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Nivolumab", "level_internal_id": 0, "level_suspended": "N"}, {"level_code": "1", "level_description": "Drug: Relatlimab", "level_internal_id": 1, "level_suspended": "N"}]}, {"arm_code": "C10: Relatlimab + Nivolumab SAV Dose 4", "arm_internal_id": 12, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Nivolumab", "level_internal_id": 0, "level_suspended": "N"}, {"level_code": "1", "level_description": "Drug: Relatlimab", "level_internal_id": 1, "level_suspended": "N"}]}, {"arm_code": "C12: Relatlimab + Nivolumab SAV Dose 5", "arm_internal_id": 13, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Nivolumab", "level_internal_id": 0, "level_suspended": "N"}, {"level_code": "1", "level_description": "Drug: Relatlimab", "level_internal_id": 1, "level_suspended": "N"}]}, {"arm_code": "C8: Relatlimab + Nivolumab SAV + PDCT Dose 1", "arm_internal_id": 14, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Nivolumab", "level_internal_id": 0, "level_suspended": "N"}, {"level_code": "1", "level_description": "Drug: Relatlimab", "level_internal_id": 1, "level_suspended": "N"}]}, {"arm_code": "C9: Relatlimab + Nivolumab SAV + Bevacizumab", "arm_internal_id": 15, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Nivolumab", "level_internal_id": 0, "level_suspended": "N"}, {"level_code": "1", "level_description": "Drug: Relatlimab", "level_internal_id": 1, "level_suspended": "N"}, {"level_code": "2", "level_description": "Drug: Bevacizumab", "level_internal_id": 2, "level_suspended": "N"}]}, {"arm_code": "C11: Relatlimab + Nivolumab SAV + PDCT Dose 2", "arm_internal_id": 16, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Nivolumab", "level_internal_id": 0, "level_suspended": "N"}, {"level_code": "1", "level_description": "Drug: Relatlimab", "level_internal_id": 1, "level_suspended": "N"}]}, {"arm_code": "D1: Nivolumab + Temozolomide", "arm_internal_id": 17, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Nivolumab", "level_internal_id": 0, "level_suspended": "N"}, {"level_code": "1", "level_description": "Drug: Temozolomide", "level_internal_id": 1, "level_suspended": "N"}]}, {"arm_code": "D2: Nivolumab + Rucaparib", "arm_internal_id": 18, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Nivolumab", "level_internal_id": 0, "level_suspended": "N"}, {"level_code": "1", "level_description": "Drug: Rucaparib", "level_internal_id": 1, "level_suspended": "N"}]}, {"arm_code": "D3: Nivolumab + Daratumumab", "arm_internal_id": 19, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Nivolumab", "level_internal_id": 0, "level_suspended": "N"}, {"level_code": "1", "level_description": "Drug: Daratumumab", "level_internal_id": 1, "level_suspended": "N"}]}, {"arm_code": "D4: Nivolumab + Bevacizumab", "arm_internal_id": 20, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Nivolumab", "level_internal_id": 0, "level_suspended": "N"}]}, {"arm_code": "E1: Bevacizumab Monotherapy", "arm_internal_id": 21, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Bevacizumab", "level_internal_id": 0, "level_suspended": "N"}]}, {"arm_code": "E2: Regorafinib Monotherapy", "arm_internal_id": 22, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Regorafinib", "level_internal_id": 0, "level_suspended": "N"}]}, {"arm_code": "E4: Leucovorin + Oxaliplatin + Fluorouracil", "arm_internal_id": 23, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Leucovorin", "level_internal_id": 0, "level_suspended": "N"}, {"level_code": "1", "level_description": "Drug: Fluorouracil", "level_internal_id": 1, "level_suspended": "N"}, {"level_code": "2", "level_description": "Drug: Oxaliplatin", "level_internal_id": 2, "level_suspended": "N"}]}, {"arm_code": "E5: Enzalutamide Monotherapy", "arm_internal_id": 24, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Enzalutamide", "level_internal_id": 0, "level_suspended": "N"}]}, {"arm_code": "E6: Sunitinib Monotherapy", "arm_internal_id": 25, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Sunitinib", "level_internal_id": 0, "level_suspended": "N"}]}, {"arm_code": "E7: Rucaparib Monotherapy", "arm_internal_id": 26, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Rucaparib", "level_internal_id": 0, "level_suspended": "N"}]}, {"arm_code": "E8: Capecitabine Monotherapy", "arm_internal_id": 27, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Capecitabine", "level_internal_id": 0, "level_suspended": "N"}]}, {"arm_code": "E9: Cabozantinib Monotherapy", "arm_internal_id": 28, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Cabozantinib", "level_internal_id": 0, "level_suspended": "N"}]}, {"arm_code": "E10: Pemetrexed Monotherapy", "arm_internal_id": 29, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Pemetrexed", "level_internal_id": 0, "level_suspended": "N"}]}, {"arm_code": "E11: Pembrolizumab Monotherapy", "arm_internal_id": 30, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Pembrolizumab", "level_internal_id": 0, "level_suspended": "N"}]}, {"arm_code": "E3: Leucovorin + Fluorouracil", "arm_internal_id": 31, "arm_description": {}, "arm_suspended": "N", "dose_level": [{"level_code": "0", "level_description": "Drug: Leucovorin", "level_internal_id": 0, "level_suspended": "N"}]}], "match": [{"and": [{"clinical": {"oncotree_primary_diagnosis": "", "disease_status": ["", ""]}}, {"genomic": {"hugo_symbol": "", "variant_category": ""}}]}]}]}}